Here are five key notes from the transaction:
• Shares were sold at an average price of $37.90
• The total transaction was $947,000
• Mr. Widensohler now owns 456,019 shares directly in LDR stock
• Mr. Widensohler’s shares are now valued at $17.3 million
• The transaction took place on March 3
LDR has a market cap of $1 billion and a 50-day moving average of $36.21. The company’s stock has a consensus rating of “buy” and consensus price target of $41.52. Zacks downgraded LDR shares in late February to “neutral” but Brean Capital initiated coverage on the company the same day and set a “buy rating.”
More articles on orthopedic devices:
5 key trends in the global bio-implants market
Danbury Orthopedics 1st in Connecticut to offer MAKOplasty procedures
SpineGuard partners with Zavation to bring smart screws to the U.S.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
